New insights into leishmaniasis in the immunosuppressed
- PMID: 29746470
- PMCID: PMC5944929
- DOI: 10.1371/journal.pntd.0006375
New insights into leishmaniasis in the immunosuppressed
Abstract
Immunosuppression contributes significantly to the caseload of visceral leishmaniasis (VL). HIV coinfection, solid organ transplantation, malnutrition, and helminth infections are the most important immunosuppression-related factors. This review briefly describes the challenges of these associations. East Africa and the Indian subcontinent are the places where HIV imposes the highest burden in VL. In the highlands of Northern Ethiopia, migrant rural workers are at a greater risk of coinfection and malnutrition, while in India, HIV reduces the sustainability of a successful elimination programme. As shown from a longitudinal cohort in Madrid, VL is an additional threat to solid organ transplantation. The association with malnutrition is more complex since it can be both a cause and a consequence of VL. Different regimes for therapy and secondary prevention are discussed as well as the role of nutrients on the prophylaxis of VL in poverty-stricken endemic areas.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Hassan MF, Zhang Y, Engwerda CR, Kaye PM, Sharp H, Bickle QD. The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani. Am J Pathol. 2006;169(3):943–53. Epub 2006/08/29. doi: 10.2353/ajpath.2006.051319 ; PubMed Central PMCID: PMCPMC1698825. - DOI - PMC - PubMed
-
- La Flamme AC, Scott P, Pearce EJ. Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages. Parasite Immunol. 2002;24(7):339–45. Epub 2002/08/08. . - PubMed
-
- O'Neal SE, Guimaraes LH, Machado PR, Alcantara L, Morgan DJ, Passos S, et al. Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis. J Infect Dis. 2007;195(1):142–8. Epub 2006/12/08. doi: 10.1086/509808 . - DOI - PubMed
-
- Newlove T, Guimaraes LH, Morgan DJ, Alcantara L, Glesby MJ, Carvalho EM, et al. Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis. Am J Trop Med Hyg. 2011;84(4):551–5. Epub 2011/04/05. doi: 10.4269/ajtmh.2011.10-0423 ; PubMed Central PMCID: PMCPMC3062447. - DOI - PMC - PubMed
-
- Wolday D, Berhe N, Britton S, Akuffo H. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS. 2000;14(8):921–9. Epub 2000/06/15. . - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
